Dr. Jeffery Talbert
Dr. Jeffery Talbert

Director

Jeffery Talbert Ph.D. is Professor in the Department of Pharmacy Practice and Science, UK College of Pharmacy, Director of the Institute for Pharmaceutical Outcomes and Policy, Associate Director of the UK Center for Clinical and Translational Science. He received B.S., M.A., and Ph.D. degrees from Texas A& M University. Professor Talbert has research interests in pharmaceutical policy, Medicaid policy, and public health informatics.

Interests

  • Pharmaceutical Policy, Health Policy, Medicaid Policy, Biomedical Informatics

Recent Publications

  • Brown J D, Shewale A R, Dherange P, Talbert Jeffery C. (2016). Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed. Journal of the American College of Cardiology, 68(22), 2492.
  • Brown J D, Doshi P A, Pauly N J, Talbert Jeffery C. (2016). Rates of Neonatal Abstinence Syndrome Amid Efforts to Combat the Opioid Abuse Epidemic. JAMA pediatrics, 170(11), 1110-1112.
  • Brown J D, Shewale A R, Talbert Jeffery C. (2016). Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation. Journal of managed care & specialty pharmacy, 22(11), 1319-1329.
  • Sohn Minji, Talbert Jeffery C, Moga Daniela Claudia, Blumenschein Karen M. (2016). A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy. Attention deficit and hyperactivity disorders, 8(3), 149-58.
  • Brown J D, Talbert Jeffery C. (2016). Hospital Variation and Patient Characteristics Associated With Vena Cava Filter Utilization. Medical care,
  • Brown J D, Talbert Jeffery C. (2016). Variation in the Use of Vena Cava Filters for Venous Thromboembolism in Hospitals in Kentucky. JAMA surgery,
  • Brown J D, Shewale A R, Dherange P, Talbert Jeffery C. (2016). A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras. Drugs & aging, 33(6), 427-36.
  • Pauly N J, Talbert Jeffery C, Brown J. (2016). Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data. Journal of managed care & specialty pharmacy, 22(6), 741-51.
  • Sohn Minji, Moga Daniela Claudia, Blumenschein Karen M, Talbert Jeffery C. (2016). National trends in off-label use of atypical antipsychotics in children and adolescents in the United States. Medicine, 95(23), e3784.
  • Pauly Nathan, Slavova Svetla Stefanova, Talbert Jeffery C, Rippetoe Freeman Patricia E. (2016). Fifty State Analysis of the Impact of Prescription Drug Monitoring Programs on Rates of Opioid Prescribing in The United States. Academy of Managed Care Pharmacy Annual Meeting,